Assessment of the proarrhythmic effects of repurposed antimalarials for COVID-19 treatment using a comprehensive in vitro proarrhythmia assay (CiPA)

MLA

Seung-Hyun Yoon, et al. “Assessment of the Proarrhythmic Effects of Repurposed Antimalarials for COVID-19 Treatment Using a Comprehensive in Vitro Proarrhythmia Assay (CiPA).” Frontiers in Pharmacology, vol. 14, Aug. 2023. EBSCOhost, https://doi.org/10.3389/fphar.2023.1220796.

APA

Seung-Hyun Yoon, Hyun-Lee Lee, Da Un Jeong, Ki Moo Lim, Seong-Jun Park, & Ki-Suk Kim. (2023). Assessment of the proarrhythmic effects of repurposed antimalarials for COVID-19 treatment using a comprehensive in vitro proarrhythmia assay (CiPA). Frontiers in Pharmacology, 14. https://doi.org/10.3389/fphar.2023.1220796

Chicago

Seung-Hyun Yoon, Hyun-Lee Lee, Da Un Jeong, Ki Moo Lim, Seong-Jun Park, and Ki-Suk Kim. 2023. “Assessment of the Proarrhythmic Effects of Repurposed Antimalarials for COVID-19 Treatment Using a Comprehensive in Vitro Proarrhythmia Assay (CiPA).” Frontiers in Pharmacology 14 (August). doi:10.3389/fphar.2023.1220796.